Abstract
Background Central obesity affects about 4 out of every 10 people globally, and it is a notable public health concern linked with premature morbidity and mortality. In Kenya, regional studies have approximated the prevalence to range from 37% to 50%. However, these studies have been done in specific regions or population groups, such as among urban residents or women. Therefore, we aimed to assess the general and sex-specific prevalence and determinants of central obesity among adults in Kenya.
Methods An analysis of the prevalence and determinants of central obesity was assessed using data from the 2015 Kenya STEPwise survey on non-communicable diseases and injuries. We included a final sample of 4 003 participants. Participants’ characteristics and prevalence of central obesity were described and summarized using frequencies and percentages. The bivariate and multivariate logistic regression were used to assess the determinants of central obesity.
Results The overall weighted prevalence of central obesity was 46.7% [95% confidence interval (CI): 43.2, 50.3], with women exhibiting a significantly higher prevalence compared to men (58.3% vs. 35.6%, p=0.001). Sex, age, household wealth index, and smoking were among the factors significantly associated with central obesity. Men had 66% lower odds of central obesity compared to women, while the risk increased with age, ranging from 1.6 to 4 times higher odds among those aged 30—39 and 50—69 years, respectively, compared to 18—29–year–olds. Other predictors of central obesity were wealthier households and non-smoking.
Conclusion About half of the adult Kenyan population is centrally obese, with a higher prevalence among women than men. Kenya’s policymakers should consider targeting high-risk groups in this population to reduce the burden of central obesity.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
We did not receive any form of funding or financial assistance.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The 2015 Stepwise survey participants provided written informed consent, and the Kenya Medical Research Institute Scientific Ethics and Review Unit approved the survey. The dataset was accessed from the Kenya National Bureau of Statistics data repository after a user's agreement was completed and access was granted.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
Data used in this study can be accessed from the Kenya National Bureau of Statistics website at http://statistics.knbs.or.ke/nada/index.php/catalog.
List of abbreviations
- BMI
- Body Mass Index
- CO
- Central Obesity
- CI
- Confidence Interval
- LMICs
- Low–and Middle–Income Countries
- NCDs
- Non-communicable Diseases
- OR
- Odds Ratio
- WC
- Waist Circumference
- WHR
- Waist-to-Hip Ratio
- WHtR
- Waist-to-Height Ratio
- WHO
- World Health Organization
